Last Funding Type: Series C
Total Funding: 197100000.0
Last Funding Date: 2019-12-05
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Investors Number: 16.0
Founded Date: 2017-01-01
Headquarters: Cambridge, Massachusetts, United States
Industry: End-to-End Drug Development